Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Perinatol. 2014 Aug 7;35(1):23–28. doi: 10.1038/jp.2014.139

Table 3.

Maternal serum 25(OH)D at and risk of operative delivery in 2798 singleton pregnancies.

25(OH)Da Cases % with outcome Unadjusted risk ratio 95% CI Adjustedb risk ratio 95% CI
Primary cesarean delivery 52 1.9
 <30 nmol/L 13 1.9 Reference Reference
 30–49 nmol/L 14 1.5 0.78 0.37 – 1.64 0.76 0.38 – 1.55
 50–74 nmol/L 19 2.5 1.28 0.64 – 2.57 1.22 0.61 – 2.44
 ≥75 nmol/L 6 1.4 0.70 0.27 – 1.84 0.65 0.24 – 1.81
Indicated instrumental deliveryc, d 211 7.6
 <30 nmol/L 50 7.6 Reference Reference
 30–49 nmol/L 63 6.9 0.91 0.63 – 1.31 0.84 0.57 – 1.22
 50–74 nmol/L 61 8.1 1.07 0.74 – 1.54 0.92 0.63 – 1.35
 ≥75 nmol/L 36 8.4 1.10 0.72 – 1.68 0.88 0.56 – 1.39
Primary cesarean or indicated instrumental delivery c 262 9.4
 <30 nmol/L 63 9.5 Reference Reference
 30–49 nmol/L 77 8.3 0.88 0.64 – 1.22 0.83 0.60 – 1.16
 50–74 nmol/L 80 10.5 1.11 0.81 – 1.52 1.00 0.72 – 1.39
 ≥75 nmol/L 42 9.7 1.02 0.70 – 1.50 0.87 0.58 – 1.30

Note: All data based on combined results from 5 imputed datasets.

Abbreviation: 25(OH)D, 25-hydroxyvitamin D.

a

25(OH)D measured at ≤26 weeks gestation.

b

Adjusted for prepregnancy BMI, race/ethnicity, and study site (except cesarean models adjusted for latitude instead of study site). Conditional logistic regression models conditioned on study site and adjusted for prepregnancy BMI and race/ethnicity yielded similar results.

c

Vaginal delivery by forceps or vacuum excluding those with “elective” listed as indication.

d

n=2759 women who entered stage 2 labor.